Clinical Trials Browser

Phase 2 × Completed × patritumab deruxtecan × Clear all

NCT04699630 2026-05-22

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Phase 2 Completed

121 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05865990 2026-05-04

TUXEDO-3

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms